Introduction Part C:
The Work Of The Dr. Rath Health Foundation

  1. In the following part of my response, I will outline the work of the Dr Rath Health Foundation – the second Respondent – as well as other Respondents, associated with it. Just as in the previous section, I will present detailed background information not only about its present work of our Foundation in South Africa , but also about its history.
  2. AIDS is a matter of life and death for millions of people in Africa and around the world and there is a great need for the people and the governments of the world for effective, safe and affordable public health strategies to combat this disease. Equally important is the assurance that the help provided is free of commercial interests and serves only the interests of the people affected by this epidemic.
  3. Unfortunately, this is not the case. We have already seen specific “ruses” being set up to channel money from drug companies to promote their merchandise. Economically by far the biggest global “ruse” is the Foundation of software billionaire Bill Gates. The “Gates Foundation” spends hundreds of millions of Rand to promote ARV drugs – e.g. in South Africa - and sponsors global ARV promoting rallies rivaling the UN’s Special conferences – all the while this Foundation has made strategic investments into pharmaceutical companies worth billions of Rand (Annexure ‘Gates L.A. Times’).
  4. Thus, there existed a great need for a foundation that is driven by non-profit motives from top to bottom. Before going into details of the work of our foundation in South Africa, I will briefly describe my scientific accomplishments for the record.

Scientific Contributions By Dr. Rath

  1. As for my professional background: I graduated from the medical school of the University of Hamburg, Germany, and subsequently held clinical and research positions at the University of Hamburg as well as the “German Heart Center” in Berlin. In 1990, I accepted the invitation of two-time Nobel Laureate Linus Pauling to head the cardiovascular research at the “Linus Pauling Institute of Science and Medicine” in Palo Alto, California .
  2. Linus Pauling had received two unshared Nobel Prizes, in Chemistry (1954) and Peace (1963). He was a pioneer in many fields of science, including biochemistry, biology, molecular biology and medicine. Among others, he discovered the first structures of proteins as well as the first genetic disease, sickle cell anaemia.
  3. During my time at the “Linus Pauling Institute of Science and Medicine,” I published a series of landmark scientific publications, many of them together with Dr Pauling and today, I am privileged to state that no other living scientist has published more scientific publications with Dr Pauling. Some of these publications appeared in the official journal of the US National Academy of Sciences.
  4. Over the years, my scientific publications have appeared in international scientific and medical journals, including those of the “American Heart Association”, the “European Heart Association”, the “US National Academy of Sciences” and others. A list of the more than 80 scientific contributions I authored or co-authored is annexed hereto (Annexure ‘Dr. Rath Scientific Contributions’).
  5. My first research interest was in the area of cardiovascular disease and I was privileged to contribute important discoveries to this field, answering questions that had previously been unanswered in conventional cardiology, i.e. “Why do we get infarctions in the heart, but rarely in other organs?“ or “Why do we get atherosclerosis (hardening of the arteries), but not veno-sclerosis (hardening of the veins)”? None of the existing theories about the origin of cardiovascular disease, e.g. the “cholesterol-theory” could obviously explain these phenomena.
  6. In short, our research in this field established, among others, that a) the instability of the blood vessel walls is a primary risk factor for the development of cardiovascular disease, b) the primary cause of this instability is a deficiency of vitamin C and other micronutrients in millions of cells that make up the blood vessel wall and c) cardiovascular disease can be described as an early form of the “sailors’ disease” scurvy characterized by vitamin deficiency resulting in “brittle” blood vessels. A comprehensive description of this research would go beyond the scope of this affidavit and I refer the Honourable Court to my list of publications and the Website of our Research Institute (
  7. In the context of this litigation, my basic research into the field of cancer and viral diseases is even more relevant. My discoveries in this field discovery ultimately lead to identifying natural ways that help block the spread of viruses through the connective tissue by natural means (Annexure ‘Plasmin Study’). The most important steps of these discoveries can be described, in short, in the following way:
    1. Many viruses and other micro-organisms are known to use the same mechanisms to migrate through the human body that is used by white blood cells under normal conditions (e.g. to fight an infection) and by cancer cells under disease conditions.
    2. Cells infected by a virus (as well as all cancer cells) produce certain enzymes that operate like biological scissors in cutting the surrounding connective tissue, mostly collagen molecules. The production of these collagen-digesting enzymes (“collagenases”) is a precondition for the spread of viral infections (as well as the cancer spread and metastasis).
    3. While some of these mechanisms had been identified by researchers before, the importance of this mechanism for finding effective therapies against cancer and viral diseases had not been understood. More importantly, this knowledge had not been applied to medicine, and little – if any – medical research had been conducted focusing on these important therapeutic targets.
    4. I was privileged to discover that a combination of certain vitamins and other micronutrients could effectively block the spread of cancer cells as well as viruses.
  8. Over the past years, our team of researchers under the leadership of Dr Aleksandra Niedzwiecki, Ph.D., has confirmed the ability of micronutrients to block this mechanism for
    1. Cancer cells. Certain micronutrients than thirty different types of human cancer cells – including such common cancer types as breast, prostate, bone, brain, skin and others.
    2. Viruses. Because viral diseases use the same enzymes to spread, it was not surprising, that the same micronutrients would prove effective in blocking such widespread viruses as the influenza virus, but also retroviruses.
    In this context, I also refer to the affidavit of Dr Niedzwiecki as the fifth Respondent. Most of this research has been published in peer-reviewed international scientific journals and I annex an overview of these studies . The complete text of these scientific publications can be accessed on the web site of the Dr Rath Research Institute.
  9. These scientific advances have been complemented by the expertise of Dr Raxit Jariwalla, a renowned virologist, who has recently joined our research team. Among other positions, Dr Jariwalla had been head of virology at the Linus Pauling Institute of Science and Medicine and already in 1990 his team had published a landmark study in the “Proceedings of the National Academy of Science.” Dr Jariwalla and his colleagues could document in in vitro studies that ascorbic acid (vitamin C) alone can almost completely inhibit the replication of HIV viruses (Annexure ‘Harakeh Jariwalla Pauling 1990’). For further details, I refer to the affidavit of Dr Jariwalla.